Opportunities and challenges in Nano-structure mediated drug delivery: where do we stand? (2016)
Awasthi, Rajendra; Pant, Isha; Kulkarni, Giriraj T; Kikuchi, Irene Satiko 
; Pinto, Terezinha de Jesus Andreoli ; Dua, Kamal; Malipeddi, Venkata Ramana
Source: Current Nanomedicine. Unidade: FCF
Assunto: MEDICAMENTO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
AWASTHI, Rajendra et al. Opportunities and challenges in Nano-structure mediated drug delivery: where do we stand?. Current Nanomedicine, v. 6, n. 2, p. 78-104, 2016Tradução . . Disponível em: http://benthamscience.com/journals/current-nanomedicine/article/144609/. Acesso em: 16 nov. 2024.APA
Awasthi, R., Pant, I., Kulkarni, G. T., Kikuchi, I. S., Pinto, T. de J. A., Dua, K., & Malipeddi, V. R. (2016). Opportunities and challenges in Nano-structure mediated drug delivery: where do we stand? Current Nanomedicine, 6( 2), 78-104. Recuperado de http://benthamscience.com/journals/current-nanomedicine/article/144609/NLM
Awasthi R, Pant I, Kulkarni GT, Kikuchi IS, Pinto T de JA, Dua K, Malipeddi VR. Opportunities and challenges in Nano-structure mediated drug delivery: where do we stand? [Internet]. Current Nanomedicine. 2016 ; 6( 2): 78-104.[citado 2024 nov. 16 ] Available from: http://benthamscience.com/journals/current-nanomedicine/article/144609/Vancouver
Awasthi R, Pant I, Kulkarni GT, Kikuchi IS, Pinto T de JA, Dua K, Malipeddi VR. Opportunities and challenges in Nano-structure mediated drug delivery: where do we stand? [Internet]. Current Nanomedicine. 2016 ; 6( 2): 78-104.[citado 2024 nov. 16 ] Available from: http://benthamscience.com/journals/current-nanomedicine/article/144609/
